Circulating Breast cancer-associated microRNA expression in serum as Biomarker for Breast cancer detection
No Thumbnail Available
Date
2019-01
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Addis Abeba University
Abstract
Background: Breast cancer (BC) is a type of cancer that develops/grows in breast tissues. It is
one of the leading causes of death among women worldwide. Breast cancer is the most frequent
cancer and the second leading cause of cancer death among women in industrialized countries.
Although it is curable if diagnosed and treated appropriately at an early stage of the disease,
diagnosis remains a challenge to the clinicians. The value of current histological prognostic
indicators in predicting the course of the disease is weak and reliable markers are still lacking.
Therefore, these gaps have led to significant interest in the quest for minimally invasive markers
that are sensitive enough to detect early the presence of tumours in patients but not in healthy
tumour-free individuals.
Objective: was to investigate the capability of circulating microRNAs in serum to discriminate
breast cancer patients from healthy controls.
Methods: The study was conducted from June 2017 to August 2018 at Tikur Anbessa
Specialized University Hospital.A case control study design was conducted involving 50
participants (25 cases, 25 controls). Five milliliter of blood samples were collected and serum
was separated from each patient and healthy controls. miRNAs were extracted from serum
samples and their relative expression levels were determined by quantitative real time PCR. Data
were analyzed using SPSS software (version 25.0, Chicago, IL, USA) and Graph pad Prism
version 7. After CT values were analyzed using Microsoft Excel 2010, independent t test and one
way ANOVA was done to assess significance of the difference between patients and controls.
Data were presented as mean ± SD. Values were considered statistically significant when Pvalue
was
less than
0.05.
Results: We reported that breast cancer specific circulating miRNAs level showed significant
difference in breast cancer patients as compared to healthy controls. The expression level of
miR-21 and miR-195 were significantly higher (P=0.003, P=0.042 respectively) in serum of
breast cancer patients than healthy controls. While there was no significant difference in
expression of miR-145 and miR-130b.Furthermore we showed that miR-21 and miR-195
expression level were higher in surgical operated breast cancer patients. Conclusion: Circulating miR-21 and miR-195 are potential breast cancer biomarkers for breast
cancer.
Description
Keywords
Biomarkers, Breast cancer, Clinicopathological, Micro RNA